What is the fair value of COO stock?

Our analysis estimates the fair value range for COO to be between $61.43 and $77.60. The current price is $54.61.

What is the analyst price target for COO?

The average Wall Street analyst price target for COO is $66.21. This implies a potential upside of 21.2% from current levels.

The Cooper Companies (COO) Stock: Buy, Sell, or Hold?

COO - The Cooper Companies, Inc. Common Stock

OPHTHALMIC GOODS

$54.61

1.34 (2.52%) ▲

5d: -13.97%

30d: -27.28%

90d: -18.92%

WAIT

LOW Confidence

Protect Your COO Gains

Analysis Updated: Sep 16, 2026 12:00 AM ET

Earnings: Sep 09, 2026 0d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 8, 2026 at $68.11 · last confirmed Sep 15, 2026

Strength: 8.0/10

Get Alerted When COO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
⏸️ WAIT FOR STABILIZATION: COO is down 14.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 3.6%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$83.71

Based on 3.8% avg growth

INTRINSIC VALUE TODAY

$51.98

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.8x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: COO is currently trading at $54.61, which is considered oversold relative to its 30-day fair value range of $61.43 to $77.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.6) compared to its historical average (14.8). Remarkably, the market is currently pricing in an annual earnings decline of 7.7% over the next few years. This pessimistic expectation contrasts with the company's recent 357.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, COO is in a uptrend. Immediate support is located at $51.01, while resistance sits at $71.07.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $66.21 (+21.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $61.43 - $77.60

Company Quality Score 50/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 79.5%

Protect Your Profits

Holding COO? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (40/100)
BULLISH: High volume confirmation
BULLISH: Trading 21.2% below Wall St target ($66.21)
WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $61.43 - $77.60

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $51.01

Resistance Level $71.07

Current Trend Uptrend

Technical data as of Sep 16, 2026

Fundamental Context

Forward P/E (Next Year Est.) 11.63

Wall Street Target $66.21 (+21.2%)

Revenue Growth (YoY) 0.6%

Earnings Growth (YoY) 357.1%

Profit Margin 13.5%

Valuation Discount vs History -7.7% cheaper

PE vs Historical 11.6 vs 14.8 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -7.7% (market-implied from PE analysis)

1-Year Target $50.41 (-8%)

2-Year Target $46.52 (-15%)

3-Year Target $42.94 (-21%)

3-Yr Target (if PE normalizes) (PE: 12→15) $54.62 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.2, Growth: 3.6%) $105.45 (+93%)

Base: (SPY PE: 11.6, Growth: 3.6%) $60.77 (+11%)

Bear: (PE: 9.9, Growth: 3.6%) $51.65 (-5%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (12x PE) as earnings recover.

Trailing PE: 18.63 | Current EPS (TTM): $2.86

Bull Case $96.17 (+76%)

Analyst growth 64.1%, PE expands to 20.5

Base Case $87.43 (+60%)

Market implied 64.1%, PE stable at 18.6

Bear Case $36.22 (-34%)

Severe decline -20.0%, PE contracts to 15.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 11.6 to 14.8

Stabilization Target: $69.47 (+27.2%)

PE Expansion Potential: +27.2%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 17, 2026 12:43 AM ET
Data refreshes hourly during market hours. Next update: 1:43 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is COO showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for COO.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ISRG Intuitive Surgical Inc	BUY 33 analysts	$478	50 HOLD
ALC Alcon AG	STRONG BUY 27 analysts	$85	52 HOLD
RGEN Repligen Corporation	STRONG BUY 19 analysts	$189	55 HOLD
WST West Pharmaceutical Serv…	STRONG BUY 13 analysts	$405	52 HOLD
RMD ResMed Inc	BUY 19 analysts	$246	48 HOLD

ISRG Intuitive Surgica…

50 HOLD

ALC Alcon AG

52 HOLD

RGEN Repligen Corporat…

55 HOLD

WST West Pharmaceutic…

52 HOLD

RMD ResMed Inc

48 HOLD

Advanced COO Option Strategies

Professional options setups generated by AI based on today's COO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for COO

COO Technical Chart COO Price Prediction COO Earnings Date Why is COO Moving Today? COO Investment Advisor COO Fair Price Analyzer COO Options Advisor COO Options Chain COO Options Analysis COO Competitors

Compare COO with Peers

COO vs TFX
Which one to buy?

COO vs MTD
Which one to buy?

COO vs STE
Which one to buy?

COO vs XRAY
Which one to buy?

COO vs RMD
Which one to buy?

COO vs SOLV
Winner: COO

HSIC vs COO

ALGN vs COO
Winner: COO

COO vs MTD

COO vs HOLX

COO vs STAA
Winner: COO

WAT vs COO

XRAY vs COO
Winner: COO

BDX vs COO

COO vs AVTR

Create New Comparison View All Competitors

Tradestie